EFTA02444816.pdf

Quesc .4 O Diagnostic QUEST DIAGNOSTICS INCORPORATED PATIENT INFORMATION EPSTE1N,JEFFREY REPORT STATUS PARTIAL REPRINT ORDERING PHYSICIAN CLIENT SERVICE DOB: 01/20/1953 AGE: 57 GENDER: M FASTING: SPECIMEN INFORMATION CLIENT INFORMATION SPECIMEN: K4671284 T11886 10013650 REQUISITION: PHONE: WOODSON MERRELL. M.D. 44 E 67TH STREET NEW YORK, NY 10065 COLLECTED: 03/03/2010 11:50 RECEIVED: 03/03/2010 21:07 REPORTED: 03/09/2010 17:30 The original copy of this report was printed on: 03/09/2010 at 08:16 Patient results contained In a facsimi le or electronic medical report are provided only upon the request of the physician or authorized person. Facsimile or electronic medical reports that are created before the final results are reported are considered to be INTERIM RESULTS ONLY and are subject to change by the laboratory. Test Name In Range Out of Range Reference Range Lab 1GF-1 151 87-Z25 ng/mL TBR FSH 3.7 1.6-8.0 mIU/nL TBR LH 4.1 1.5-9.3 mill/ML TBR PROLACTIN 2.6 2.0-18.0 ng/mL TBR PROGESTERONE 1.1 <1.4 ng/mL TBR DHEA SULFATE 182 25-240 mcg/dL TBR TESTOSTERON,FR/TOT,LCMSMS QNI TESTOSTERONE, TOTAL 188 L 250-1100 ng/dL Total Testosterone was measured by LCMSMS. The LCMSMS method correlates well with our extraction/RIA method. % FREE TESTOSTERONE 1.94 1.5-2.2 % TESTOSTERONE, FREE 7-346.t.i) 35.0-155.0 pg/nL MTHFR,DNA MUTATION.NY see note A RESULT: POSITIVE FOR ?WO COPIES OF THE C677T _) MUTATION DNA testing indicates this individual is homozygous for the C677T mutation and does not have the A1298C mutation. This has been associated with an increased risk for hyperhonocysteinemia and vascular diseases. Consider genetic counseling and DNA testing for at-risk members. EPSTEIN,JEFFREY - K4671284 Page 1 - Continued on Page 2 Intl, Wit lia,bistics, ee 44,4clittd leis as4 all allittotril Osewl Diers$tiff .ifil off thr trilisleks or 0.ril Dulauuf Irgerf*,atfl ill rail's WIPIM 1/6: u/va u m IIONIM VI EFTA_R1_01522013 EFTA02444816  Quest •O Diagnostic", QUEST DIAGNOSTICS INCORPORATED PATIENT INFORMATION EPSTEIN,JEFFREY REPORT STATUS PARTIAL REPRINT ORDERING PHYSICIAN DOB: 01/20/1953 AGE: 57 GENDER: M FASTING: Y SPECIMEN INFORMATION CLIENT INFORMATION SPECIMEN: X4671284 T11886 10013650 COLLECTED: 03/03/2010 11:50 REPORTED: 03/09/2010 17:30 Test Name In Range Out of Range Reference Range Lab Laboratory testing supervised and results monitored by U.N. Pratt, Ph.D.. FACMG, Director, Molecular Genetics. Hyperhomocysteinemia is a risk factor for arterial disease and venous thrombosis. Homocysteine levels are affected by nutritional and genetic factors. Since MINER is involved in methylation of homocysteine to methionine, individuals with MTHFR gene mutations that reduce enzyme activity may develop hyperhoncysteinenia and thus be at risk for vascular disease. The C677T and A1298C mutations are detected by signal amplification of the MTHFR gene by allele- specific hybridizations and chemi luminescent detection of hybridized probes. Since genetic variation and other factors can affect the accuracy of direct mutation testing, these results should be interpreted in light of clinical and familial data. This test was developed and its performance characteristics have been determined by Quest Diagnostics Nichols Institute, Chantilly, UA. It has not been cleared or approved by the U.S. Food and Drug Administration. The FDA has determined that such clearance or approval is not necessary. Performance characteristics refer to the analytical performance of the test. ESTRAD1CL,ULTRASEN,LEMSMS PENDING PERFORMING LABORATORY INFORMATION: AND Quest Diagnostics Nichols Chantilly 14225 Neubrook Drive Chantilly VA Z0151 Laboratory Director: Kenneth Slsco. MD.PhD CLIA No: 4900221801 QN1 Quest Diagnostics, Nichols Institute 33608 Ortega Highway San Juan Capistrano CA 92690 Laboratory Director: Dr. Jon M. Nakamoto CLIA No: 05110643352 1BR Quest Diagnostics One Malcolm Avenue Teterboro NJ 07608 Laboratory Director: William E. Tarr, M.D. CLIA No: 3100695246 EPSTEIN,JEFFREY - X4671Z84 Page Z - End of Report MOW Wit liet, tit isimiltd ail ill irsocialttl lwl harosItts irks art be Dadasarkt el kept Diatnett In Intrpornd ell riials rtivted Winn VII $141/9 ftle IAMIU V) EFTA_R1_01522014 EFTA02444817  44n Quest Diagnostics) PATIENT INFORMATION REPORT STATUS FINAL ESPSTE1N.JEFFREY REPRINT QUEST DIAGNOSTICS INCORPORATED ORDERING PHYSICIAN CLIENT SERU10E DOB: 01/28/1953 AGE: 57 GENDER: M FASTING: SPECIMEN INFORMATION CLIENT INFORMATION SPECIMEN: X4666434 111886 10013650 REQUISITION: PHONE: WOODSON MERRELL. M.D. 44 E 67TH STREET NEW YORK. NY 10065 COLLECTED: 03/03/2010 08:20 RECEIVED: 03/03/2010 20:43 REPORTED: 03/08/2010 08:32 The original copy of this report was printed on: 03/05/2010 at 08:16 Test Name In Range Out of Range Reference Range Lab LEAD,BLOOD <3 <10 mcg/dL TBR Blood lead levels in the range of 5-9 mcg/dL have been associated with adverse health effects In children aged 6 years and younger. Industrial Exposure: (40 mcg/dL mcg/dL x mcg/100g for OSHA (refer to current governmental regulations for exposure criteria) MERCURY.BLOOD 5 (x10 mcg/L AND ARSENICAILOOD 4 ¢3 ncg/L AMD Urine is usually the best specimen for the analysis of Arsenic in body fluids. Blood levels tend to be low even when urine concentrations are high. PERFORMING LABORATORY INFORMATION: AND Quest Diagnostics Nichols Chantilly 14225 Newbrook Drive Chantilly VA 20151 Laboratory Director: Kenneth Sisco, MD,PhD CLIA No: 4900221801 TBR Quest Diagnostics One Malcolm Avenue Teterboro NJ 07608 Laboratory Director: William E. Tarr, M.D. CLIA No: 31D0696246 ESPSTEIN.JEFFREY - K4666434 Page 1 - End of Report frost, frost Input.'., iI, asocatiol loge ad at asocial.' last floristin ear ire no trartutors if Ivor floristic. locaporita. Ill feria anat.. Orlatt. I II 934VA M:31 /11111111 20 EFTA_R1_01522015 EFTA02444818  fl ak Quest Diagnostict PATIENT INFORMATION REPORT STATUS FINAL EPSTEIN, JEFFREY WEST b:AanosTics INCORPORATED ORDERING PNUIcIAN CLIENT SERVICE DOD: 01/20/1953 AGE: 57 GENDER: M FASTING: Y SPECIMEN INFORMATION CLIENT INFORMATION SPECIMEN: F7579815 T11886 10013650 REQUISITION: PHONE: WOODSON MERRELL, M.D. 44 E 67TH STREET NEW YORK, NY 10065 COLLECTED: 03/03/2010 11:50 RECEIVED: 03/03/2010 21:49 REPORTED: 03/05/2010 10:31 Test Name In Range Out of Range Reference Range Lab CALCIUM 8.6-10.2 mg/dL TBR FTIGINTACT 8.9 H 10-65 pg/mL TER Interpretive Guide Intact PT Calcium Normal Parathyroid Function Normal Normal Hypoparathyroidism Low or Low Normal Low Primary Hyperparathyroidism Normal or High High Secondary Hyperparathyroidism High Normal or Low Tertiary Hyperparathyroidism High High Non-Parathyroid Hypercalcemia Low or Low Normal High PERFORMING LABORATORY INFORMATION: TBR *Nest Diagnostics One Malcolm Avenue Teterboro NJ 07608 Laboratory Director: William E Tarr. M.D. CLIA No: 3100696246 EPSTEIN,JEFFREY - F7579815 Page 1 - End of Report Dog CuntPerm. /]snot vs< kgnei N..sww Lest Wichill en. Mae Sera. RoiltDersagii 4 .631.0 MW0MIWN At•ro tattosell On411 / .Old SU sot lot, EFTA_R1_01522016 EFTA02444819  Quest gest Diagnostics tar? te r Diagnostics One Malcolm Avenue Tetedxso New Jersey 07608-1070 QuestTrack Intact Parathyroid Hormone Date of Report: 01/06/2010 T11886 10013650 Patient Name: WOODSON MERRELL, M.D. Ordering Physician: Jeffrey Epstein 44 E 67th Street Identification Number: New York, NY 10065 Route: 10013650 Account Number: Age: 57 Sex: M TI IMO too® Intact Parathyroid 9000 axe Hormone 7000 Test No. 1222A 6000 Date Received: 03103/2010 5000 Accession II F7579815 4000 Results (Please refer to the official Medical Report) Intact PTH 68.90 pg/mL I Normal Range 10 - 65 pg/mL) Total Calcium 10.40 mg/dL (Female Range 8.5 - 10.3 mg/c1L- 1000 Male Range 8.7 - 10.4 mg/d1 ) 900 BOO 700 600 SOO Legend 403 Normal -E a, no Indeterminate Secondary Hyperparathyroidism 5 100: Primary Hyperparathyroidism .c4€ 0.50L • Hypoparathyroidism Non-Parathyroid I Hypercalcomia 10 9 a 7 I Note: The reference range on the graph may 6 differ from the reference range cited for this patient. The comparison data set on the back of this report includes both male and female patients. The reference ranges for calcium on 3 the graph are those that would be applied to an adult patient where sex was unspecified. 2.0 4.0 6.0 6.0 100 170 140 160 C 2002 Gam Dmonomics Incorporad VIM 11$0.Ved Calcium tmg/d0 Oust Oust 0.40444044, en moons logo and all assevabse Guest Diagnostics marks We Ihe trilidemel• of Quest (Ns irost ,t s I ^c ()wilted EFTA_R1_01522017 EFTA02444820  4IPlk Quest ja4, Diagnostic PATIENT INFORMATION REPORT STATUS FINAL EPSTEIN, JEFFREY QUEST DIAGNOSTICS INCORPORATED ORDERING PHYSICIAN CLIENI' SERVICE DOB: 01/20/1953 AGE: 57 GENDER: M FASTING: Y SPECIMEN INFORMATION Chi 2N7 INFORmAT ION SPECIMEN: 92116012 T11886 10013650 REQUISITION: PHONE: WOODSON MERRELL, M.D. 44 E 67TH STREET NEW YORK, NY 10065 COLLECTED: 03/03/2010 08:20 RECEIVED: 03/03/2010 19:57 REPORTED: 03/08/2010 08:16 Test Name In Range Out of Range Reference Range Lab MAGNESIUM 1.8 1.5-2.5 mg/dL TBR TSH,3RD GENERATION 1.77 0.40-4.50 mIU/L TBR THYROID PANEL TBR T4,TOTAL 9.4 4.5-12.5 mcg/dL Please note new reference range. T3 UPTAKE 32 22-35 Percent T4,FREE,CALCULATED 3.0 1.4-3.8 Units CK,TOTAL 2621 H 44-196 U/L TBR EPSTEIN,JEFFREY - 92116012 Page 1 - Continued on Page 2 Bost Os Owens S ass sd me, ol atellAjitC Cam illsso. st , w, imp Nash rip Os Wyss i Est Swots swoops./ A I MS 'sits! 111)211:0417L M. nai SOB SCN ISM EFTA_R1_01522018 EFTA02444821  ak Quest Diagnostic® PAT [ENT INFORMATION REPORT STATUS FINAL EPSTEIN, JEFFREY DIAGNGSTICS INCORPORATED ORDERING PHYSICIAN DOB: 01/20/1953 AGE: 57 GENDER: M FASTING: Y MIN INFORMATION CLIENT IN FORK* r ION CIMIN: 92116012 T11886 10013650 LECTED: 03/03/2010 08:20 URTED: 03/08/2010 08:16 sat Name In Range Out of Range Reference Range Lab S/HDL/TIBC W FER RFX/FRUCTOSAMINE TB?? GLUCOSE,FASTING e04) 65-99 mg/dL FRUCTOSAMINE 246 190-270 umol/L SODIUM 140 135-146 mmol/L POTASSIUM 4.4 3.5-5.3 mmol/L CHLORIDE 105 98-110 mmol/L CARBON DIOXIDE 24 21-33 mmol/L UREA NITROGEN 18 7-25 mg/dL CREATININE 0.94 0.76-1.46 mg/dL BUN/CREATININE RATIO NOTE 6-22 Bun/Creatinine ratio is not reported when the Bun and Creatinine values are within normal/14 its. URIC ACID PHOSPHORUS 3.3 8.6 H 4.0-8.0 mg/dL 2.5-4.5 mg/dL t CALCIUM 10.0 8.6-10.2 mg/dL CHOLESTEROL,TOTAL 200 125-200 mg/dL HDL CHOLESTEROL L >=40 mg/dL CHOLESTEROL/HDL'RATIO H < = 5.0 LDL CHOL, CALCULATED 111 <130 mg/dL See footnote 1 TRIGLYCERIDES H <150 mg/dL PROTEIN,TOTAL 7.4 6.2-8.3 g/dL ALBUMIN 4.6 3.6-5.1 g/dL GLOBULIN,CALCULATED 2.8 2.1-3.7 g/dL A/G RATIO 1.6 1.0-2.1 BILIRUBIN,TOTAL 0.7 0.2-1.2 mg/dL BILIRUBIN,DIRECT 0.1 < = 0.2 mg/dL ALKALINE PHOSPHATASE 64 40-115 U/L GGT 12 3-85 U/L AST 21 10-35 U/L ALT 19 9-60 U/L LD 152 120-250 U/L IRON,TOTAL 70 45-170 mcg/dL TIBC 314 250-425 mcg/dL TRANSFERRIN SATURATION 22 20-50 % PIEIN,JEFFREY - 92116012 Page 2 - Continued on Page 3 &OK 'Ma DOOPWICI OW • 510141•1 CIF MeM ais+calDest Dwyer"' • nen Pe the •••••••••As v Ores. 0u,rnU c 0•040$1•LtilliV 'Aid At oath gown. C031100.NYI Peva/IV* dlOt New EFTA_R1_01522019 EFTA02444822  Ank Quest Diagnostics PATIENT INFORMATION REPORT STATUS FINAL EPSTEIN,JEFFREY WEST DIAGNOSTICS INCORPORATED ORDERING DOB: 01/20/1953 AGE: 57 GENDER: M FASTING: Y SPECIMEN INFORMATION "21. I 1:N: IN f", ,MA71r-N SPECIMEN: 92116012 T11886 10013650 COLLECTED: 03/03/2010 08:20 REPORTED: 03/08/2010 08:16 Teat Name In Range Out of Range Reference Range Lab CBC (INCLUDES DIFF/PLT) TBR WBC 5.3 3.8-10.8 ThOus/mCL RBC 5.06 4.20-5.80 Mill/mcL HEMOGLOBIN 15.0 13.2-17.1 g/dL HEMATOCRIT 44.8 38.5-50.0 % MCV 88.5 80.0-100.0 fL MCH 29.6 27.0-33.0 pg MCHC 33.4 32.0-36.0 g/dL RDW 13.4 11.0-15.0 % PLATELET COUNT 289 140-400 Thous/mcL MPV 7.9 7.5-11.5 fL TOTAL NEUTROPHILS,t 49.7 38-80 % TOTAL LYMPHOCYTES,t 34.9 15-49 % MONOCYTES,t 7.5 0-13 % EOSINOPHILS,t 7.2 0-8 % BASOPHILS,% 0.7 0-2 % NEUTROPHILS,ABSOLUTE 2634 1500-7800 Cells/mcL LYMPHOCYTES,ABSOLUTE 1850 850-3900 Cells/mcL MONOCYTES,ABSOLUTE 398 200-950 Cells/mcL EOSINOPHILS,ABSOLUTE 382 15-550 Cells/mcL BASOPHILS,ABSOLUTE 37 0-200 Cells/mcL DIFFERENTIAL An instrument differential was performed. URINALYSIS, COMPLETE TBR COLOR Yellow Yellow APPEARANCE Cloudy • Clear GLUCOSE,QL Negative Negative mg/dL BILIRUBIN,URINE Negative Negative KETONES Negative Negative mg/dL SPECIFIC GRAVITY 1.024 1.001-1.035 BLOOD (1+) • Negative PH 5.5 5.0-8.0 PROTEIN,TOTAL,QL Negative Negative mg/dL NITRITE Negative Negative LEUKOCYTE ESTERASE Negative Negative SQUAMOUS EPITHELIAL CELLS None Seen cor=5 cells/hpf WBC None Seen cor=5 cells/hpf BACTERIA None Seen None Seen /hpf RBC t19 corn3 cells/hpf HYALINE CASTS None Seen None Seen /lpf EPSTEIN,JEFFREY - 92116012 Page 3 - Continued on Page 4 0.4ot rhas0,49.6n. no ow,oo, nx nMrMeiGw.ly.m...mt non.R ono••kl•Oill V al ..)oregone • 40,N lextra, °ownerre ...itemrows. OMIXONTIL qtrs." 91/1 Sac EFTA_R1_01522020 EFTA02444823  Ank Quest 74 Diagnostics 6 PATIENT INFORMATION EPSTEIN, JEFFREY REPORT STATUS FINAL QUEST DIAGNOSTICS INCORPORATED ORDERING PHYSICIAN DOB: 01/20/1953 AGE: 57 GENDER: M FASTING: Y SPECIMEN INPUSMNP:ON CLIENT INFORMATION SPECIMEN: 92116012 T11886 10013650 COLLECTED: 03/03/2010 08:20 REPORTED: 03/08/2010 08:16 Test Name In Range Out of Range Reference Range Lab VITAMIN B12 4. FOLATE TBR VITAMIN B12,SERUM Q53 /) 200-1100 pg/mL Please note: although the reference range for Vitamin B12 is 200-1100 pg/mL, it has been reported that between 5 and 10% of patients with values between 200 and 400 pg/mL may experience neuropsychiatric and hematologic abnormalities due to occult B12 deficiency; less than 1% of patients with values above 400 pg/mL will have symptoms. FOLATE,SERUM 10.6 > 5.4 ng/mL Normal: >5.4 Borderline: 3.4.5.4 Low: <3.4 CARDIO CRP (R) 0.8 mg/L TBR Low relative cardiovascular risk according to AHA/CDC guidelines. See footnote 2 PSA,TOTAL 0.54 <=4.0 ng/mL TBR See footnote 3 APOLIPOPROTEIN A -1+B TBR APOLIPOPROTEIN Al 117 __ 94-176 mg/dL APOLIPOPROTEIN B 107 52-109 mg/dL APOLIPOPROTEIN B/A1 RATIO 0.91 Below average risk: <0.29 Average risk: 0.29-1.30 Above average risk: >1.30 HEMOGLOBIN AlC H Percent TBR Reference Range: Non Diab 6.0% HOMOCYSTEINE,CARDIO TBR HOMOCYSTEINE 11: <11.4 M/CROmol/L EPSTEIN,JEFFREY - 92116012 Page 4 - Continued on Page 5 0so.Choi Papenta Imp +.4 a. ea Pora*.• ^Phi st• PaNn." CNN, 0NV*Pcs t CUM, 0.91.11< 10(01W. WA A ' ,nano/ 0DNOWNTL SP SUS ISSN EFTA_R1_01522021 EFTA02444824  Quest e Diagnostics PAV.F.NT EPSTEIN, JEFFREY REPORT STATUS FINAL QUEST DIAGNOSTICS INCORPORATED ORDERING PHYSICIAN DOB: 01/20/1953 AGE: 57 GENDER: M FASTING: Y SPECIMEN INFORMATION CLIENT INFORMATION SPECIMEN: 92116012 T11886 10013650 COLLECTED: 03/03/2010 08:20 REPORTED: 03/08/2010 08:16 Test Name In Range Out of Range Reference Rang. Lab VITAMIN D,25-0H,LC/MS/MS TBR VITAMIN D, 25-0H, TOTAL 42 20-100 ng/mL VITAMIN D, 25-OH, D3 42 ng/mL VITAMIN D, 25-OH, D2 <4 ng/mL 25-OHD3 indicates both endogenous production and supplementation. 25-OHD2 is an indicator of exogenous sources such as diet or supplementation. Therapy is based on measurement of Total 25-OHD, with levels <20 ng/mL indicative of Vitamin D deficiency, while levels between 20 ng/mL and 30 ng/mL suggest insufficiency. Optimal levels are >30 ng/mL. MAGNESIUM,RBC 4.6 4.0-6.4 mg/dL AMD FOOTNOTE(S): 1 Desirable range is <100 mg/dL for patients with coronary heart disease (CHD) or diabetes, and <70 mg/dL for diabetic patients with known CHD. 2 For Ages >17 Years: CCRP mg/L Risk according to AHA/CDC guidelines <1.0 Low cardiovascular risk 1.0 - 3.0 Average cardiovascular risk 3.1 - 10.0 High cardiovascular risk >10.0 Persistent elevations may represent non-cardiovascular inflammation 3 This test was performed using the Siemens (Bayer) chemiluminescent method. Values obtained from different assay methods cannot be used interchangeably. PSA levels, regardless of value, should not be interpreted as absolute evidence of the presence or absence of disease. PERFORMING LABORATORY INFORMATION: AMD Quest Dtagnostics Nichpls Chanc,lly 14225 NewbrOOK Drive Chantilly VA 20151 Laboratory Director: Kenneth Risco, MD,PhD CLIA No: 49D0221801 113R Quest Diagnostics One Malcolm Avenue Teterboro NJ 07608 Laboratory Director: William E. Tarr. M.D. CLIA No: 3100696246 EPSTEIN,JEFFREY - 92116012 Page 5 - End of Report Owg.tlauti.n...“ 7r anway, ur Ind a 40-CifrIlaudaltrinitrrar r•tkeesitasitaaGuu.aribbot• I. ntpearl Airrarmer.< aommeratfteemn. SCA mewl EFTA_R1_01522022 EFTA02444825  441% Quest Diagnostics PATIENT INFORMATION REPORT STATUS FINAL EPSTEIN,JEFFREY QUEST DIAGNCSTIcS INCORPORATED ORDERING PHYSICIAN CLIENT SERVICE DOB: 01/20/1953 AGE: 57 GENDER: M FASTING: Y SPECIMEN INFORMATION CLIENT INFORMATION SPECIMEN: P7579848 T11886 10013650 REQUISITION: PHONE: WOODSON MERRELL, M.D. 44 E 67TH STREET NEW YORK, NY 10065 COLLECTED: 03/03/2010 08:20 RECEIVED: 03/03/2010 21:52 REPORTED: 03/08/2010 08:16 Test Name In Range Out of Range Reference Range Lab INSULIN,FREE 7.8 1.5-14.9 uIU/mL QNI Insulin levels vary widely in specimens taken from non-fasting individuals. PERFORMING LABORATORY INFORMATION: QNI Quest Oiagnostics. Nichols Institute 2760E Ortega Highway San Juan Capistrano CA 92690 LabOratOry Director: Dr. Jon N. Nekamoto CLIA No: 050643152 EPSTEIN,JEFFREY - F7579848 Page 1 - End of Report Chats' aaWD.I..104. .1.,..elin•ra ...Ana. city Meo Onwon sets of TI.t rmlivtis el114.,Davuour t. asul>.ipaibeebtwante• AlIhronne int 0020IWIL AteseJtil 501 USA EFTA_R1_01522023